A Dopamine Pathway Gene Risk Score for Cognitive Recovery Following Traumatic Brain Injury: Methodological Considerations, Preliminary Findings, and Interactions With Sex.
A Dopamine Pathway Gene Risk Score for Cognitive Recovery Following Traumatic Brain Injury: Methodological Considerations, Preliminary Findings, and Interactions With Sex.
复制标题
创伤性脑损伤后认知恢复的多巴胺通路基因风险评分:方法学考虑、初步发现以及与性的相互作用。
DOI:
10.1097/htr.0000000000000199
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Wagner,AmyK
中科院分区:
文献类型:
--
作者:
Myrga,JohnM;Failla,MichelleD;Ricker,JosephH;Dixon,CEdward;Conley,YvetteP;Arenth,PatriciaM;Wagner,AmyK
Objectives:With evidence of sexual dimorphism involving the dopamine (DA)-pathway, and the importance of DA pathways in traumatic brain injury (TBI) recovery, we hypothesized that sex× DA-gene interactions may influence cognition post-TBI.Participants:Adult survivors of severe TBI (n= 193) consecutively recruited from a level 1 trauma center.Design:Risk allele assignments were made for multiple DA pathway genes using a sex-specific stratified approach. Genetic risk alleles, and their impacts on cognition, were assessed at 6 and 12 months postinjury using unweighted, semiweighted, and weighted gene risk score (GRS) approaches.Main Measures:A cognitive composite score generated from 8 standardized neuropsychological tests targeting multiple cognitive domains.Results:A significant sex× gene interaction was observed at 6 and 12 months for ANKK1 rs1800497 (6M: P=. 002, 12M: P=. 001) and COMT rs4680 (6M: P=. 048; 12M: P=. 004); DRD2 rs6279 (P=. 001) and VMAT rs363226 (P=. 043) genotypes were independently associated with cognition at 6 months, with trends for a sex× gene interaction at 12 months. All GRS methods were significant predictors of cognitive performance in multivariable models. Weighted GRS multivariate models captured the greatest variance in cognition: R 2= 0.344 (6 months); R 2= 0.441 (12 months), significantly increasing the variance captured from the base prediction models.Conclusions:A sex-specific DA-pathway GRS may be a valuable tool when predicting cognitive recovery post-TBI. Future work should validate these findings and explore how DA-pathway genetics may guide therapeutic intervention.